BB BIOTECH AG
Follow13F filer, CIK 924223, SCHAFFHAUSEN, Switzerland
BB BIOTECH AG filed a 13F-NT notice for the quarter ended 2026-09-30 on 2026-11-16.
Accepted , ingested 13F-NT 0001104659-26-128586
This filer reports no holdings of its own for Q3 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.
Changes against Q2 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.
Part of the filer group Bellevue Group AG
Bellevue Asset Management AGBellevue Asset Management (UK) Ltd.
- Bellevue Asset Management AG
- Bellevue Asset Management (UK) Ltd.
- Bellevue Group AG
- Bellevue Asset Management AG
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-NT 0001104659-26-128586 | notice | 2026-11-16 |